Journal
NEUROPSYCHOPHARMACOLOGY
Volume 25, Issue 4, Pages 585-600Publisher
NATURE PUBLISHING GROUP
DOI: 10.1016/S0893-133X(01)00244-5
Keywords
CRF1 receptors; 5-HT1A receptors; 5-HT2C receptors; benzodiazepines; anxiety
Categories
Ask authors/readers for more resources
The selective, non-peptidergic corticotropin-releasing factor (CRF), receptor antagonists, CP154,526 and DMP695, dose-dependently increased punished responses Of rats in a Vogel conflict test and enhanced social interaction (SI) of rats in an unfamiliar environment. They were, however, inactive in a plus-maze procedure and failed to reduce ultrasonic vocalizations (USV) associated with an aversive environment. In contrast, the benzodiazopine, chlordiazepoxide, was effective in all these procedures. Further, the serotonin (5-HT)(1A) agonist, flesinoxan, was active in each paradigm (except the plus-maze) while the 5-HT2C antagonist, SB242,084, was effective in the S1 and Vogel but not the plus-maze and USV procedures. In contrast to chlordiazepoxide, flesinoxan and SB242,084, CP154,526 did not modify dialysate levels of 5-HT, norepinephrine (NE) and dopamine (DA) in the frontal cortex (FCX) of freely moving rats. In conclusion, CP154,526 and DMP695 possess a common and distinctive profile of anxiolytic action expressed in the absence of an intrinsic influence upon monoamine release.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available